SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-08-009073
Filing Date
2008-08-11
Accepted
2008-08-08 18:09:12
Documents
10
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2186974z10-q.htm 10-Q 974923
2 EXHIBIT 10.3 a2186974zex-10_3.htm EX-10.3 28386
3 EXHIBIT 10.4 a2186974zex-10_4.htm EX-10.4 24480
4 EXHIBIT 10.5 a2186974zex-10_5.htm EX-10.5 68313
5 EXHIBIT 10.6 a2186974zex-10_6.htm EX-10.6 70868
6 EXHIBIT 10.7 a2186974zex-10_7.htm EX-10.7 1293014
7 EXHIBIT 31.1 a2186974zex-31_1.htm EX-31.1 7623
8 EXHIBIT 31.2 a2186974zex-31_2.htm EX-31.2 7623
9 EXHIBIT 32.1 a2186974zex-32_1.htm EX-32.1 3519
10 EXHIBIT 32.2 a2186974zex-32_2.htm EX-32.2 3524
  Complete submission text file 0001047469-08-009073.txt   2483661
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14680 | Film No.: 081003895
SIC: 2836 Biological Products, (No Diagnostic Substances)